Back

Angiotensin receptor-neprilysin inhibition improves peak oxygen consumption in reduced heart failure patients

26 May 2019 (08:30 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 2 - Chronic Heart Failure – Treatment Pharmacotherapy HFA Premium Access Heart Failure 2019

About the speaker

Photo
Miss Catia Ferreira

Coimbra University, Coimbra (Portugal)

55 More presentations in this session

Presentation thumbnail
Doctor A. Ntalianis (Athens, GR)
Abstract
Presentation thumbnail
Doctor J. AGOSTINHO (Lisbon, PT)
Abstract
Presentation thumbnail
Doctor F. Ferreira (Lisbon, PT)
Abstract
Presentation thumbnail
Ms E. O'Donoghue (Dublin, IE)
Abstract
Presentation thumbnail
Doctor V. Gomez Leiva (San Salvador, SV)
Abstract Slides

Access the full session

Session thumbnail
Poster Session 2 - Chronic Heart Failure – Treatment

The Event

Event poster

Heart Failure 2019

26 May 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Sacubitril/valsartan improves exercise performance in patients with heart failure: a dose-dependent effect
24 June 2023
thumbnail
Congress Presentation
Angiotensin receptor-neprilysin inhibitor-based therapy among adult heart failure patients with below normal systemic ventricular ejection fraction and complex congenital heart disease
31 August 2025
thumbnail
Congress Presentation
Age-stratified and sex-stratified effect of angiotensin receptor-neprilysin inhibitor in heart failure with reduced ejection fraction-data from PARADE-HF: nationwide medication adherence study
12 May 2024
thumbnail
Congress Session
Pioneering advances in HFrEF management: unlocking the potential of sGC stimulation
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources